|
Zyla Health, India’s top-rated personalised healthcare management platform focused on improving health outcomes, has announced its strategic growth in new geographies in Southeast Asia after a successful regional launch in 2024. The expansion is a result of strong traction and effective results from Zyla's digital treatment solution among cardiometabolic patients.
Hundreds of Southeast Asian doctors now prescribe Zyla's AI-based solution to hypertension, diabetes, dyslipidemia, chronic heart failure, and comorbid conditions patients. The outcome: enhanced healthcare results, higher patient activation, and a quantifiable change in everyday health habits.
Zyla's solution is designed specifically for globalisation. Its patient management system follows global coding standards such as ICD-10, LOINC, ATC, and CPT to ensure easy integration with health systems globally. It’s genetic AI-powered proprietary lifestyle intervention engine links diseases to nutritional and lifestyle interventions. This allows for quick and correct localisation for various geographies with a robust scientific core. Also, local care teams adapt the interventions to local languages, cultures, and habits of life, which makes them highly relevant and effective.
Zyla's digital therapy solution in global markets has been shown to exhibit high patient adherence and significant health outcomes. On average, onboarded patients spend 12 minutes per day actively interacting with the app, a testament to strong adoption and ongoing interaction. Interestingly, 75 per cent of patients remain active with the platform into their second quarter of care, above even India's retention rates. In addition, 50 per cent plus users have indicated significant symptom improvement, highlighting the power of Zyla's tailored, AI-driven model of care.
Khushboo Aggarwal, CEO of Zyla Health, said, “Our mission is to deliver high-quality, personalised care to the farthest reaches of the globe. The initial success we have achieved in Southeast Asia demonstrates that with the right combination of technology, medical knowledge, and local customisation, we can facilitate meaningful and sustainable health outcomes worldwide. We are thrilled to now extend this revolutionary care model to even more parts of Southeast Asia.”
Zyla Health enables care at scale for health insurers, pharmaceutical and large enterprises through the AI-powered Zyla Health app (consistently rated 4.7+).
The care Zyla Health implements spans across medical, physical, and mental health needs, powered by a complete in-house team of doctors, nutritionists, psychologists and other specialists. The process begins with a detailed health risk assessment of the population, followed by personalised care journeys ranging from chronic disease management to wellness programmes.
|